A pilot study of cisplatin based combination chemotherapy in gastric cancer
Related Experiment Videos
A McDonald1, M Harding, L McNulty
1Department of Medical Oncology, Glasgow Royal Infirmary, UK.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|January 1, 1993
Abstract:
A pilot study evaluating cisplatin in combination with 5-fluorouracil, methotrexate and epirubicin in advanced gastric cancer was initiated. Twenty patients were treated, eight with locally advanced or recurrent disease, and 12 with metastatic gastric cancer. The overall response rate was 35% (95% confidence interval 14%-56%).